Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study
These findings indicate that prescribing practices for cannabis may not adequately consider the implications of DARSCIC/DNTI. Enhancing prescriber awareness of these interactions could mitigate the risk of adverse effects such as drug-related intoxication.
Authors
- Zoumana Cheick Bérété (ORCID: https://orcid.org/0000-0002-1263-5623)
- Arsène Zongo (ORCID: https://orcid.org/0000-0001-8812-3088)
- Cerina Dubois (ORCID: https://orcid.org/0000-0001-6465-8686)
- Dean T. Eurich (ORCID: https://orcid.org/0000-0003-2197-0463)
- Jason R.B. Dyck (ORCID: https://orcid.org/0000-0002-7045-2884)
- John G. Hanlon
- Arvis Abraham Sebgo
Institutions
- St. Michael's Hospital (CA)
- Johns Hopkins University (US)
- University of Alberta (CA)
- University of Toronto (CA)
- Johns Hopkins Medicine (US)
- Provincial Laboratory of Public Health (CA)
- Centre hospitalier universitaire de Québec (CA)
- Université Laval (CA)
Publication Details
- Journal
- Age and Ageing
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1093/ageing/afaf359
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00